Related Experiment Video

Updated: Dec 18, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.5K

Percutaneous Coronary Intervention (PCI) Strategies under Hemodynamic Support for Cardiogenic Shock: A Single-Center

Talha Ahmed1, Diljon Chahal2, Ronson J Madathil2

  • 1University of Maryland Medical Center Midtown Campus, USA.

Case Reports in Cardiology
|June 19, 2020
PubMed

Insights

Two cases of cardiogenic shock complicating acute myocardial infarction (CSAMI) were treated with mechanical circulatory support (MCS) using venoarterial extracorporeal membrane oxygenation (VA-ECMO). While successful decannulation was achieved, the patients experienced unfavorable outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Surgery
  • Intensive Care Medicine

Background:

  • Cardiogenic shock complicating acute myocardial infarction (CSAMI) presents a critical challenge in cardiovascular medicine.
  • Mechanical circulatory support (MCS) offers a potential therapeutic avenue for patients with severe CSAMI.
  • Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a form of MCS used in refractory CSAMI.

Observation:

  • This report details two cases of profound CSAMI managed with VA-ECMO.
  • The VA-ECMO enabled complex, high-risk, and staged percutaneous coronary interventions.
  • Successful weaning from VA-ECMO (decannulation) was achieved in both patients.

Findings:

  • Despite successful VA-ECMO support and intervention, both patients ultimately had unfavorable outcomes.
  • The findings highlight the limitations of current therapeutic strategies in CSAMI, even with advanced MCS.
  • The complexity of CSAMI necessitates careful consideration of MCS and intervention risks versus benefits.

Implications:

  • These cases underscore the need for further research into optimizing CSAMI management strategies.
  • Developing improved criteria for patient selection and treatment protocols for VA-ECMO in CSAMI is crucial.
  • Understanding the factors contributing to unfavorable outcomes despite successful MCS and intervention is essential for advancing patient care.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K
The Intra-Aortic Balloon Pump06:13

The Intra-Aortic Balloon Pump

Published on: February 5, 2021

23.8K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
153
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
378
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
169
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
538